Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,917 | 514 | 97.0% |
| Education | $243.01 | 11 | 3.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,097 | 72 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $793.24 | 38 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $647.52 | 36 | $0 (2020) |
| Astellas Pharma US Inc | $603.30 | 27 | $0 (2023) |
| GlaxoSmithKline, LLC. | $509.12 | 42 | $0 (2022) |
| Amgen Inc. | $462.65 | 26 | $0 (2020) |
| Lilly USA, LLC | $440.97 | 35 | $0 (2020) |
| SANOFI-AVENTIS U.S. LLC | $405.75 | 25 | $0 (2020) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $403.99 | 26 | $0 (2020) |
| Merck Sharp & Dohme Corporation | $380.77 | 31 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $78.60 | 3 | Astellas Pharma US Inc ($29.56) |
| 2022 | $18.27 | 1 | GlaxoSmithKline, LLC. ($18.27) |
| 2021 | $32.68 | 2 | AbbVie Inc. ($32.68) |
| 2020 | $372.55 | 20 | Novo Nordisk Inc ($68.51) |
| 2019 | $2,321 | 146 | Novo Nordisk Inc ($351.98) |
| 2018 | $2,389 | 157 | Novo Nordisk Inc ($399.12) |
| 2017 | $2,948 | 196 | AstraZeneca Pharmaceuticals LP ($305.61) |
All Payment Transactions
525 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $29.56 | General |
| Category: Biological | ||||||
| 12/14/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $24.21 | General |
| Category: Diabetes | ||||||
| 07/20/2023 | Azurity Pharmaceuticals, Inc. | Horizant (Drug) | Food and Beverage | Cash or cash equivalent | $24.83 | General |
| Category: Sleep | ||||||
| 06/10/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.27 | General |
| Category: RESPIRATORY | ||||||
| 08/03/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: NEUROSCIENCE | ||||||
| 02/09/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: NEUROSCIENCE | ||||||
| 03/05/2020 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: UROLOGY | ||||||
| 03/05/2020 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $12.75 | General |
| Category: Obesity | ||||||
| 03/02/2020 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: Neuroscience | ||||||
| 02/28/2020 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $21.85 | General |
| Category: Endocrinology | ||||||
| 02/27/2020 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $16.56 | General |
| Category: Cardiovascular | ||||||
| 02/20/2020 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: Virology & Specialty Care | ||||||
| 02/20/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/19/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/13/2020 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $20.84 | General |
| Category: Diabetes | ||||||
| 02/13/2020 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: UROLOGY | ||||||
| 02/10/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $33.19 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/06/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: Diabetes | ||||||
| 02/06/2020 | PFIZER INC. | CHANTIX (Drug), EUCRISA, COLOGUARD | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 02/05/2020 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $24.06 | General |
| Category: Neuroscience | ||||||
| 02/03/2020 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $17.28 | General |
| Category: GASTROENTEROLOGY | ||||||
| 01/31/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $25.88 | General |
| Category: DIABETES | ||||||
| 01/22/2020 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $24.30 | General |
| Category: UROLOGY | ||||||
| 01/13/2020 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $21.42 | General |
| Category: Endocrinology | ||||||
| 01/10/2020 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 956 | 1,267 | $213,667 | $72,347 |
| 2022 | 14 | 1,113 | 1,516 | $200,736 | $84,459 |
| 2021 | 17 | 1,199 | 1,744 | $235,447 | $102,766 |
| 2020 | 18 | 1,170 | 1,601 | $201,286 | $80,763 |
All Medicare Procedures & Services
61 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 184 | 184 | $61,605 | $24,991 | 40.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 214 | 366 | $78,258 | $23,437 | 29.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 128 | 188 | $56,758 | $18,928 | 33.3% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 73 | 114 | $2,814 | $1,085 | 38.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 79 | 82 | $5,488 | $869.75 | 15.8% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 15 | 17 | $2,275 | $791.11 | 34.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 17 | 17 | $1,241 | $552.50 | 44.5% |
| 81002 | Urinalysis, manual test | Office | 2023 | 150 | 157 | $1,616 | $535.37 | 33.1% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 11 | 11 | $1,540 | $440.60 | 28.6% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 17 | 17 | $690.00 | $334.73 | 48.5% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 52 | 98 | $1,202 | $314.58 | 26.2% |
| 82272 | Stool analysis for blood, by peroxidase activity | Office | 2023 | 16 | 16 | $180.00 | $66.40 | 36.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 254 | 524 | $85,257 | $35,221 | 41.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 197 | 197 | $54,175 | $27,523 | 50.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 77 | 105 | $23,657 | $10,542 | 44.6% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 12 | 13 | $7,800 | $3,107 | 39.8% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 34 | 38 | $4,518 | $1,795 | 39.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 119 | 127 | $10,160 | $1,291 | 12.7% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 19 | 21 | $2,940 | $959.07 | 32.6% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 26 | 27 | $2,399 | $944.73 | 39.4% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 71 | 98 | $2,548 | $939.85 | 36.9% |
| 81002 | Urinalysis, manual test | Office | 2022 | 168 | 178 | $2,848 | $610.36 | 21.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 19 | 19 | $1,045 | $608.08 | 58.2% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2022 | 19 | 19 | $909.00 | $400.15 | 44.0% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2022 | 63 | 115 | $1,955 | $372.31 | 19.0% |
About Dr. Edwin Fierer, MD
Dr. Edwin Fierer, MD is a Internal Medicine healthcare provider based in Bloomfield, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1326062480.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Edwin Fierer, MD has received a total of $8,160 in payments from pharmaceutical and medical device companies, with $78.60 received in 2023. These payments were reported across 525 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($7,917).
As a Medicare-enrolled provider, Fierer has provided services to 4,438 Medicare beneficiaries, totaling 6,128 services with total Medicare billing of $340,334. Data is available for 4 years (2020–2023), covering 61 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Bloomfield, CT
- Active Since 07/26/2006
- Last Updated 06/22/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1326062480
Products in Payments
- Ozempic (Drug) $538.04
- XIFAXAN (Drug) $501.41
- FARXIGA (Drug) $494.89
- JARDIANCE (Drug) $423.92
- TRULICITY (Drug) $317.33
- Victoza (Drug) $237.73
- Repatha (Biological) $230.07
- JANUVIA (Drug) $228.59
- XARELTO (Drug) $215.41
- SYMBICORT (Drug) $202.59
- CHANTIX (Drug) $182.09
- VESICARE (Drug) $178.01
- TOUJEO (Drug) $176.32
- Prolia (Biological) $174.23
- INVOKANA (Drug) $146.85
- ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH (Drug) $137.26
- MYRBETRIQ (Drug) $135.25
- BYSTOLIC (Drug) $130.80
- ENTRESTO (Drug) $123.02
- SOLIQUA (Drug) $109.27
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Bloomfield
Bechara Barrak, Md, MD
Internal Medicine — Payments: $38,899
John Wenceslao, Md, MD
Internal Medicine — Payments: $36,810
Dr. Pranay Bhatt, M.d, M.D
Internal Medicine — Payments: $19,760
Dr. Roy Kellerman, Md, MD
Internal Medicine — Payments: $17,119
Sheila Silverman, Md, MD
Internal Medicine — Payments: $10,559
John Kelly, Md, MD
Internal Medicine — Payments: $8,306